Myasthenia gravis (Q29396951)

Europe PubMed Central

title

Myasthenia gravis (English)

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

14 April 2017

0 references

1

Angela Vincent

1 reference

14 April 2017

author name string

Jackie Palace

series ordinal

2

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

14 April 2017

David Hilton-Jones

series ordinal

3

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

14 April 2017

language of work or name

English

0 references

publication date

June 2001

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

14 April 2017

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

14 April 2017

volume

357

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

14 April 2017

page(s)

2122-2128

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

14 April 2017

issue

9274

1 reference

https://doi.org/10.1016%2FS0140-6736%2800%2905186-2

The natural course of myasthenia gravis: a long term follow up study

14 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Thymoma: results of 241 operated cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Strong association of HLA BW46 with juvenile onset myasthenia gravis in Hong Kong Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Paraneoplastic autoimmunity in thymus tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Ocular myasthenia: diagnostic and therapeutic problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Diaphragmatic myasthenia in mother and child

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Asymptomatic maternal myasthenia as a cause of the Pena-Shokeir phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Autoimmune Response to Acetylcholine Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Antibody heterogeneity and specificity in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Myasthenia gravis and myasthenic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

The membrane attack complex of complement at the endplate in myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Altered intrathymic T-cell repertoire in human myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Autoantibody screening in subacute cerebellar ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Acquired neuromyotonia: a new autoantibody-mediated neuronal potassium channelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Congenital myasthenic syndromes: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

1 reference

7 January 2021

Synaptic structure and development: the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Myasthenia gravis and elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Epidemiology of myasthenia gravis in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Immunotherapy in neuromuscular disorders: current and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905186-2

7 January 2021